Literature DB >> 20483387

One year of alendronate treatment lowers microstructural stresses associated with trabecular microdamage initiation.

Jessica M O'Neal1, Tamim Diab, Matthew R Allen, Brani Vidakovic, David B Burr, Robert E Guldberg.   

Abstract

Alendronate, an anti-remodeling agent, is commonly used to treat patients suffering from osteoporosis by increasing bone mineral density. Though fracture risk is lowered, an increase in microdamage accumulation has been documented in patients receiving alendronate, leading to questions about the potentially detrimental effects of remodeling suppression on the local tissue (material) properties. In this study, trabecular bone cores from the distal femur of beagle dogs treated for one year with alendronate, at doses scaled by weight to approximate osteoporotic and Paget's disease treatment doses in humans, were subjected to uniaxial compression to induce microdamage. Tissue level von Mises stresses were computed for alendronate-treated and non-treated controls using finite element analysis and correlated to microdamage morphology. Using a modified version of the Moore and Gibson classification for damage morphology, we determined that the von Mises stress for trabeculae exhibiting severe and linear microcrack patterns was decreased by approximately 25% in samples treated with alendronate compared with non-treated controls (p<0.01), whereas there was no reduction in the von Mises stress state for diffuse microdamage formation. Furthermore, an examination of the architectural and structural characteristics of damaged trabeculae demonstrated that severely damaged trabeculae were thinner, more aligned with the loading axis, and less mineralized than undamaged trabeculae in alendronate-treated samples (p<0.01). Similar relationships with damage morphology were found only with trabecular orientation in vehicle-treated control dogs. These results indicate that changes in bone's architecture and matrix properties associated with one year of alendronate administration reduce trabecular bone's ability to resist the formation of loading-induced severe and linear microcracks, both of which dissipate less energy prior to fracture than does diffuse damage. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20483387      PMCID: PMC2918636          DOI: 10.1016/j.bone.2010.05.016

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  29 in total

1.  The effects of damage and microcracking on the impact strength of bone.

Authors:  G C Reilly; J D Currey
Journal:  J Biomech       Date:  2000-03       Impact factor: 2.712

2.  Shear stress distribution in the trabeculae of human vertebral bone.

Authors:  D P Fyhrie; S J Hoshaw; M S Hamid; F J Hou
Journal:  Ann Biomed Eng       Date:  2000       Impact factor: 3.934

3.  An improved labelling technique for monitoring microcrack growth in compact bone.

Authors:  Fergal J O'Brien; David Taylor; T Clive Lee
Journal:  J Biomech       Date:  2002-04       Impact factor: 2.712

4.  Microdamage accumulation in bovine trabecular bone in uniaxial compression.

Authors:  T L Arthur Moore; L J Gibson
Journal:  J Biomech Eng       Date:  2002-02       Impact factor: 2.097

5.  The antifracture efficacy of alendronate.

Authors:  E Seeman
Journal:  Int J Clin Pract Suppl       Date:  1999-04

6.  Alterations in canine vertebral bone turnover, microdamage accumulation, and biomechanical properties following 1-year treatment with clinical treatment doses of risedronate or alendronate.

Authors:  Matthew R Allen; Ken Iwata; Roger Phipps; David B Burr
Journal:  Bone       Date:  2006-06-12       Impact factor: 4.398

7.  Age-related change in the damage morphology of human cortical bone and its role in bone fragility.

Authors:  Tamim Diab; Keith W Condon; David B Burr; Deepak Vashishth
Journal:  Bone       Date:  2005-11-02       Impact factor: 4.398

8.  Microcrack frequency and bone remodeling in postmenopausal osteoporotic women on long-term bisphosphonates: a bone biopsy study.

Authors:  Roland D Chapurlat; Monique Arlot; Brigitte Burt-Pichat; Pascale Chavassieux; Jean Paul Roux; Nathalie Portero-Muzy; Pierre D Delmas
Journal:  J Bone Miner Res       Date:  2007-10       Impact factor: 6.741

9.  Microdamage propagation in trabecular bone due to changes in loading mode.

Authors:  Xiang Wang; Glen L Niebur
Journal:  J Biomech       Date:  2006       Impact factor: 2.712

Review 10.  Hip fracture protection by alendronate treatment in postmenopausal women with osteoporosis: a review of the literature.

Authors:  Jun Iwamoto; Yoshihiro Sato; Tsuyoshi Takeda; Hideo Matsumoto
Journal:  Clin Interv Aging       Date:  2008       Impact factor: 4.458

View more
  10 in total

1.  Age-related differences in the morphology of microdamage propagation in trabecular bone.

Authors:  Jessica O Green; Jason Wang; Tamim Diab; Brani Vidakovic; Robert E Guldberg
Journal:  J Biomech       Date:  2011-08-31       Impact factor: 2.712

2.  Mechanical failure begins preferentially near resorption cavities in human vertebral cancellous bone under compression.

Authors:  C R Slyfield; E V Tkachenko; S E Fischer; K M Ehlert; I H Yi; M G Jekir; R G O'Brien; T M Keaveny; C J Hernandez
Journal:  Bone       Date:  2012-03-09       Impact factor: 4.398

3.  Age-related changes in human trabecular bone: Relationship between microstructural stress and strain and damage morphology.

Authors:  Jessica O Green; Srinidhi Nagaraja; Tamim Diab; Brani Vidakovic; Robert E Guldberg
Journal:  J Biomech       Date:  2011-07-02       Impact factor: 2.712

4.  Positive skeletal effects of cladrin, a naturally occurring dimethoxydaidzein, in osteopenic rats that were maintained after treatment discontinuation.

Authors:  K Khan; K Sharan; G Swarnkar; B Chakravarti; M Mittal; T K Barbhuyan; S P China; M P Khan; G K Nagar; D Yadav; P Dixit; R Maurya; N Chattopadhyay
Journal:  Osteoporos Int       Date:  2012-08-30       Impact factor: 4.507

5.  Three years of alendronate treatment does not continue to decrease microstructural stresses and strains associated with trabecular microdamage initiation beyond those at 1 year.

Authors:  J O Green; T Diab; M R Allen; B Vidakovic; D B Burr; R E Guldberg
Journal:  Osteoporos Int       Date:  2012-01-12       Impact factor: 4.507

6.  Fourier transform infrared imaging of femoral neck bone: reduced heterogeneity of mineral-to-matrix and carbonate-to-phosphate and more variable crystallinity in treatment-naive fracture cases compared with fracture-free controls.

Authors:  Samuel Gourion-Arsiquaud; Lyudmilla Lukashova; Jon Power; Nigel Loveridge; Jonathan Reeve; Adele L Boskey
Journal:  J Bone Miner Res       Date:  2013-01       Impact factor: 6.741

Review 7.  Microcomputed tomography: approaches and applications in bioengineering.

Authors:  Joel D Boerckel; Devon E Mason; Anna M McDermott; Eben Alsberg
Journal:  Stem Cell Res Ther       Date:  2014-12-29       Impact factor: 6.832

8.  Long-term effects of bisphosphonate therapy: perforations, microcracks and mechanical properties.

Authors:  Shaocheng Ma; En Lin Goh; Andi Jin; Rajarshi Bhattacharya; Oliver R Boughton; Bhavi Patel; Angelo Karunaratne; Nghia T Vo; Robert Atwood; Justin P Cobb; Ulrich Hansen; Richard L Abel
Journal:  Sci Rep       Date:  2017-03-06       Impact factor: 4.379

9.  Self-repair of rat cortical bone microdamage after fatigue loading in vivo.

Authors:  Bo Wu; Chan Zhang; Bo Chen; Ling Zhang; Ruchun Dai; Xianping Wu; Yebin Jiang; Eryuan Liao
Journal:  Int J Endocrinol       Date:  2013-04-10       Impact factor: 3.257

10.  Local application of an ibandronate/collagen sponge improves femoral fracture healing in ovariectomized rats.

Authors:  Jialiang Guo; Qi Zhang; Jia Li; Yansong Liu; Zhiyong Hou; Wei Chen; Lin Jin; Ye Tian; Linlin Ju; Bo Liu; Tianhua Dong; Fei Zhang; Yingze Zhang
Journal:  PLoS One       Date:  2017-11-06       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.